$4.95
0.70% today
Nasdaq, Feb 28, 04:50 pm CET
ISIN
US38246G1085
Symbol
GDRX

GoodRx Holdings Stock price

$4.98
+0.13 2.68% 1M
-3.61 42.03% 6M
+0.33 7.10% YTD
-1.61 24.43% 1Y
-22.42 81.82% 3Y
-28.02 84.91% 5Y
-28.02 84.91% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
+0.09 1.84%
ISIN
US38246G1085
Symbol
GDRX

Key metrics

Market capitalization $1.90b
Enterprise Value $2.02b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 13.15
EV/Sales (TTM) EV/Sales 2.55
P/S ratio (TTM) P/S ratio 2.40
P/B ratio (TTM) P/B ratio 2.72
Revenue growth (TTM) Revenue growth 7.14%
Revenue (TTM) Revenue $790.39m
EBIT (operating result TTM) EBIT $46.07m
Free Cash Flow (TTM) Free Cash Flow $153.53m
Cash position $423.78m
EPS (TTM) EPS $-0.04
P/E forward 79.53
P/S forward 2.35
EV/Sales forward 2.50
Short interest 7.16%
Show more

Is GoodRx Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

GoodRx Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a GoodRx Holdings forecast:

10x Buy
67%
4x Hold
27%
1x Sell
7%

Analyst Opinions

15 Analysts have issued a GoodRx Holdings forecast:

Buy
67%
Hold
27%
Sell
7%

Financial data from GoodRx Holdings

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
790 790
7% 7%
100%
- Direct Costs 144 144
13% 13%
18%
646 646
6% 6%
82%
- Selling and Administrative Expenses 382 382
2% 2%
48%
- Research and Development Expense 124 124
6% 6%
16%
141 141
34% 34%
18%
- Depreciation and Amortization 95 95
46% 46%
12%
EBIT (Operating Income) EBIT 46 46
14% 14%
6%
Net Profit -16 -16
208% 208%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about GoodRx Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GoodRx Holdings Stock News

Neutral
Seeking Alpha
about 24 hours ago
GoodRx Holdings, Inc. (NASDAQ:GDRX ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Aubrey Reynolds - Director, IR Wendy Barnes - CEO Chris McGinnis - CFO Conference Call Participants Lisa Gill - J.P. Morgan John Ransom - RJF Charles Rhyee - TD Cowen Michael Cherny - Leerink Partners Jenny Cao - Truist Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo...
Neutral
Business Wire
one day ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings platform in the U.S., has released its financial results for the fourth quarter and full year of 2024. Fourth Quarter 2024 Highlights Revenue1 of $198.6 million Net income of $6.7 million; Net income margin of 3.4% Adjusted Net Income1 of ...
Neutral
Business Wire
10 days ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading medication savings platform in the U.S., today announced its drug savings platform residing with Amazon Web Services (AWS) has earned certified status for 2025 by HITRUST for information security. This milestone underscores GoodRx's dedication to safeguarding data and maintaining specific standards of cybersecurity in hea...
More GoodRx Holdings News

Company Profile

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The firm offers information and tools to help consumers compare prices for prescription drugs. It operates applications and websites that provide prices and discounts at local and mail-order pharmacies. The company was founded in September 2015 and is headquartered in Santa Monica, CA.

Head office United States
CEO Wendy Barnes
Employees 694
Founded 2015
Website www.goodrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today